GlassScriptPhysician profile
Jeffrey Gruskay
NPI 1588674345
$3,534.54
in general payments reported to CMS, 2019-2025
37 companies · $491 in 2025
The $491 reported for 2025 was more than what 89% of Neonatal-Perinatal Medicine providers received nationally (typical 2025 total: $77.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $469 · 2021: $494 · 2022: $543 · 2023: $486 · 2024: $578 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,554.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $641.83 | 2019-2025 | Dyanavel Xr, Quillichew Er |
| Merck Sharp & Dohme LLC | $390.40 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Cranial Technologies, INC | $281.33 | 2019-2025 | Doc Band |
| Sanofi Pasteur INC. | $246.47 | 2019-2025 | |
| Glaxosmithkline, LLC. | $235.45 | 2019-2025 | Bexsero, Rotarix, Penmenvy |
| Corium, LLC | $221.67 | 2022-2025 | Azstarys |
| Pfizer INC. | $195.99 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $182.70 | 2019-2022 | |
| Kaleo, INC. | $167.11 | 2020-2024 | Auvi-Q |
| Supernus Pharmaceuticals, INC. | $111.17 | 2021-2025 | Qelbree, Qelbree |
| Vertical Pharmaceuticals, LLC | $84.29 | 2019-2024 | Relexxii |
| Ironshore Pharmaceuticals INC. | $76.25 | 2019-2023 | Jornay Pm |
| Verrica Pharmaceuticals INC. | $74.46 | 2023-2024 | Ycanth |
| Phadia US INC. | $70.09 | 2022-2025 | Immunocap |
| Adlon Therapeutics L.P. | $55.32 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $54.39 | 2025 | Jornay Pm |
| Qol Medical, LLC | $54.24 | 2022 | |
| Cepheid | $40.35 | 2023 | Genexpert |
| Sanofi-Aventis U.S. LLC | $28.57 | 2024-2025 | |
| Organon LLC | $23.80 | 2025 | |
| Abbvie INC. | $23.05 | 2021 | |
| Ironwood Pharmaceuticals, INC | $22.97 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $22.12 | 2022 | |
| Shire North American Group INC | $19.71 | 2019 | |
| Aimmune Therapeutics, INC. | $19.14 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $18.33 | 2024 | Zoryve |
| Alk-Abello, INC | $18.25 | 2023 | Ragwitek, Odactra, Grastek |
| Sobi, INC | $17.90 | 2020 | |
| Mission Pharmacal Company | $17.47 | 2019 | |
| Genentech USA, INC. | $16.07 | 2019 | |
| Uswm, LLC | $16.00 | 2021 | |
| Seqirus USA INC | $15.76 | 2025 | Flucelvax |
| Ars Pharmaceuticals Operations, INC. | $15.73 | 2025 | Neffy |
| Neos Therapeutics, LP | $14.81 | 2019 | |
| Pacira Therapeutics, INC. | $14.38 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.00 | 2019 | |
| Aytu Biopharma, INC. | $12.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Gruskay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.